The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Velleca Mark A. since year 2005.
The trader's CIK number is 1706847.
At the time of this reporting, Velleca Mark A. is the President and CEO of G1 Therapeutics, Inc. .
(stock ticker symbol GTHX).
See this page for all insider trading activities at G1 Therapeutics, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2018-01-16||GTHX||G1 Therapeutics, Inc.||Option Ex||7,500||3.72||27,900|
|2018-01-16||GTHX||G1 Therapeutics, Inc.||Sale||7,500||22.99||172,395|
|2017-12-18||GTHX||G1 Therapeutics, Inc.||Sale||7,500||20.01||150,105|
|2017-12-18||GTHX||G1 Therapeutics, Inc.||Option Ex||7,500||3.72||27,900|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Velleca Mark A. (President and CEO of G1 Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.